These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23238478)

  • 41. Rosiglitazone ameliorates diabetic nephropathy by inhibiting reactive oxygen species and its downstream-signaling pathways.
    Bao Y; Jia RH; Yuan J; Li J
    Pharmacology; 2007; 80(1):57-64. PubMed ID: 17534120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetic characteristics and alveolar bone loss in streptozotocin- and streptozotocin-nicotinamide-treated rats with periodontitis.
    Kim JH; Lee DE; Choi SH; Cha JH; Bak EJ; Yoo YJ
    J Periodontal Res; 2014 Dec; 49(6):792-800. PubMed ID: 24490978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis.
    Toblli JE; Cao G; Giani JF; Angerosa M; Dominici FP; Gonzalez-Cadavid NF
    Kidney Blood Press Res; 2011; 34(1):20-33. PubMed ID: 21071958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy.
    Sen S; Kanter M; Ustundag S; Aktas C; Dogutan H; Yalcin O
    Ren Fail; 2008; 30(10):1023-33. PubMed ID: 19016156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihypertensive and vasculo- and renoprotective effects of pioglitazone in genetically obese diabetic rats.
    Yoshimoto T; Naruse M; Nishikawa M; Naruse K; Tanabe A; Seki T; Imaki T; Demura R; Aikawa E; Demura H
    Am J Physiol; 1997 Jun; 272(6 Pt 1):E989-96. PubMed ID: 9227442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy.
    Agarwal R
    Am J Physiol Renal Physiol; 2006 Mar; 290(3):F600-5. PubMed ID: 16159895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Skimmin, a coumarin, suppresses the streptozotocin-induced diabetic nephropathy in wistar rats.
    Zhang S; Yang J; Li H; Li Y; Liu Y; Zhang D; Zhang F; Zhou W; Chen X
    Eur J Pharmacol; 2012 Oct; 692(1-3):78-83. PubMed ID: 22664227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice.
    Novelli M; Canistro D; Martano M; Funel N; Sapone A; Melega S; Masini M; De Tata V; Pippa A; Vecoli C; Campani D; De Siena R; Soleti A; Paolini M; Masiello P
    Eur J Pharmacol; 2014 Apr; 729():37-44. PubMed ID: 24530416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sitagliptin improves renal function in diabetic nephropathy in male Sprague Dawley rats through upregulating heme oxygenase-1 expression.
    Wang J; Hu L; Chen Y; Fu T; Jiang T; Jiang A; You X
    Endocrine; 2019 Jan; 63(1):70-78. PubMed ID: 30128961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trigonelline ameliorates diabetic hypertensive nephropathy by suppression of oxidative stress in kidney and reduction in renal cell apoptosis and fibrosis in streptozotocin induced neonatal diabetic (nSTZ) rats.
    Ghule AE; Jadhav SS; Bodhankar SL
    Int Immunopharmacol; 2012 Dec; 14(4):740-8. PubMed ID: 23102665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of glucose-regulated protein 78 and spliced X-box binding protein 1 in the protective effect of gliclazide in diabetic nephropathy.
    Zhang YW; Wang X; Ren X; Zhang M
    Diabetes Res Clin Pract; 2018 Dec; 146():41-47. PubMed ID: 28951332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
    Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
    Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P; Eiam-Ong S; Suwanwalaikorn S
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Flavonoid rich fraction of Punica granatum improves early diabetic nephropathy by ameliorating proteinuria and disturbed glucose homeostasis in experimental animals.
    Ankita P; Deepti B; Nilam M
    Pharm Biol; 2015 Jan; 53(1):61-71. PubMed ID: 25289530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amelioration of Diabetes-Induced Diabetic Nephropathy by Aloe vera: Implication of Oxidative Stress and Hyperlipidemia.
    Arora MK; Sarup Y; Tomar R; Singh M; Kumar P
    J Diet Suppl; 2019; 16(2):227-244. PubMed ID: 29621403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Asparagus racemosus Willd (Liliaceae) ameliorates early diabetic nephropathy in STZ induced diabetic rats.
    Somania R; Singhai AK; Shivgunde P; Jain D
    Indian J Exp Biol; 2012 Jul; 50(7):469-75. PubMed ID: 22822526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of xiaoke granule on blood glucose, urinary protein and glomerular morphology in rats with diabetic nephropathy].
    Ji XM; Wang Q; Qi F
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Jun; 24(6):534-7. PubMed ID: 15250209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.
    Hofni A; El-Moselhy MA; Taye A; Khalifa MM
    Eur J Pharmacol; 2014 Dec; 744():173-82. PubMed ID: 25446917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alteration of endothelin-1 concentration in STZ-induced diabetic rat nephropathy. Effects of a PGI(2) derivative.
    Itoh Y; Nakai A; Kakizawa H; Makino M; Fujiwara K; Kobayashi T; Kato T; Nagata M; Oda N; Katsumata H; Nagasaka A; Itoh M
    Horm Res; 2001; 56(5-6):165-71. PubMed ID: 11910202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.